![Alan Xu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alan Xu
Chief Operating Officer at Ablaze Pharmaceuticals
Alan Xu active positions
Companies | Position | Start | End |
---|---|---|---|
Ablaze Pharmaceuticals
![]() Ablaze Pharmaceuticals Pharmaceuticals: MajorHealth Technology Ablaze Pharmaceuticals is a Chinese clinical-stage pharmaceutical company founded in 2021 with a mission to bring advanced targeted radiopharmaceutical therapies to benefit cancer patients. Ablaze Pharma has secured a partnership with Rayzebio, Inc., an innovative radiopharmaceutical company based in CA, to gain exclusive development and commercial rights to a series of Rayzebio's products in the greater region. The company is based in Jing'an District, China. The company leverages its team's extensive business experience and network in cross-border product development and deal making to become the leader and partner of choice in the emerging TRT market. Alex Qiao has been the CEO of the company since 2021. | Chief Operating Officer | - | - |
Career history of Alan Xu
Training of Alan Xu
Fudan University | Undergraduate Degree |
Statistics
International
China | 3 |
Operational
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Chief Operating Officer | 1 |
Sectoral
Consumer Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Ablaze Pharmaceuticals
![]() Ablaze Pharmaceuticals Pharmaceuticals: MajorHealth Technology Ablaze Pharmaceuticals is a Chinese clinical-stage pharmaceutical company founded in 2021 with a mission to bring advanced targeted radiopharmaceutical therapies to benefit cancer patients. Ablaze Pharma has secured a partnership with Rayzebio, Inc., an innovative radiopharmaceutical company based in CA, to gain exclusive development and commercial rights to a series of Rayzebio's products in the greater region. The company is based in Jing'an District, China. The company leverages its team's extensive business experience and network in cross-border product development and deal making to become the leader and partner of choice in the emerging TRT market. Alex Qiao has been the CEO of the company since 2021. | Health Technology |
- Stock Market
- Insiders
- Alan Xu
- Experience